APR 22, 2021 2:16 AM PDT

New Method To Fast Track Drug Development

WRITTEN BY: Nouran Amin

The time it takes to respond to disease outbreaks is critical. But designing drugs to combat these disease outbreaks is often challenged with a slow process. However, researchers at the University of Colorado Boulder designed a platform, known as The Facile Accelerated Specific Therapeutic (FAST), that can quickly deliver a highly specific peptide nucleic acid therapies for in just one week. Findings were published in in Nature Communications Biology and describes how the conclusions can motivate how we may change responses to pandemics and how to address the antibiotic resistance crisis.

"The applications for the real world are immense in that we have created a platform -- not just a single therapeutic," says Kristen Eller, a PhD candidate in the Chatterjee Group, is the first author on the new paper. "It is adaptive, dynamic and can be altered to target any bacterial species that is a threat while also being modulated to develop antivirals as needed."

Learn more about disease outbreaks, interventions, and controls:

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
FEB 20, 2021
Drug Discovery & Development
Deep Brain Stimulation Offsets Epileptic Seizures
FEB 20, 2021
Deep Brain Stimulation Offsets Epileptic Seizures
Researchers from the University of Freiburg in Germany have found that deep brain stimulation (DBS) in the brain’s ...
MAR 01, 2021
Microbiology
New Therapeutic Potential for a 'Miracle Poison'
MAR 01, 2021
New Therapeutic Potential for a 'Miracle Poison'
Most people know botulism as a nasty disease and botox as a wrinkle reducer that may cause a 'frozen' look if it's overu ...
MAR 30, 2021
Cardiology
Looking at a Fertility Drug's Cardiac Safety
MAR 30, 2021
Looking at a Fertility Drug's Cardiac Safety
New drugs go through a long and arduous process before they can grace a doctor’s office. One of the last steps is ...
MAY 22, 2021
Drug Discovery & Development
FDA Approves Trials for Ketamine to Treat Parkinson's
MAY 22, 2021
FDA Approves Trials for Ketamine to Treat Parkinson's
The US FDA has approved PharmaTher’s Investigational New Drug application to begin Phase 2 clinical trials for ket ...
MAY 27, 2021
Neuroscience
Research Less Likely to Be True is Cited More
MAY 27, 2021
Research Less Likely to Be True is Cited More
Researchers from the University of California San Diego have found that non-replicable data is cited 153 times more ofte ...
JUN 07, 2021
Cell & Molecular Biology
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
JUN 07, 2021
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
Researchers are increasingly relying on cells grown in three-dimensional (3D) structures to help answer their research q ...
Loading Comments...